Elder Pharmaceuticals Ltd. - Research Center
532322 ELDERPHARM Group (Z) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Jun ' 14 | Jun ' 13 | Mar ' 12 | Mar ' 11 | Mar ' 10 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 20.57 | 20.57 | 20.57 | 20.57 | 18.89 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 765.03 | 757.26 | 671.19 | 590.55 | 455.78 |
| Loan funds | |||||
| Secured loans | 224.71 | 632.27 | 503.17 | 571.54 | 404.09 |
| Unsecured loans | 319.93 | 339.99 | 277.70 | 163.81 | 138.88 |
| Total | 1,330.23 | 1,750.09 | 1,472.63 | 1,346.46 | 1,017.63 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 599.80 | 640.71 | 627.81 | 570.94 | 535.40 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 164.89 | 156.48 | 120.20 | 95.17 | 70.10 |
| Net block | 434.91 | 484.23 | 507.61 | 475.77 | 465.31 |
| Capital work-in-progress | 304.26 | 268.36 | 191.01 | 93.03 | 65.74 |
| Investments | 3.73 | 3.90 | 21.09 | 10.87 | 19.68 |
| Net current assets | |||||
| Current assets, loans & advances | 1,192.87 | 1,451.74 | 994.63 | 951.56 | 614.32 |
| Less : current liabilities & provisions | 605.54 | 458.14 | 241.71 | 184.77 | 147.41 |
| Total net current assets | 587.33 | 993.60 | 752.91 | 766.79 | 466.91 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 1,330.23 | 1,750.09 | 1,472.63 | 1,346.46 | 1,017.63 |
| Notes: | |||||
| Book value of unquoted investments | 3.19 | 3.35 | 20.17 | 9.95 | 18.75 |
| Market value of quoted investments | 3.77 | 2.41 | 4.80 | 4.13 | 4.21 |
| Contingent liabilities | 166.95 | 217.81 | 300.86 | 108.55 | 20.60 |
| Number of equity sharesoutstanding (Lacs) | 205.37 | 205.37 | 205.37 | 205.37 | 188.57 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis